We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+9.18%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.2B
AUM Growth
-$255M
Cap. Flow
-$342M
Cap. Flow %
-28.37%
Top 10 Hldgs %
51.29%
Holding
4,943
New
709
Increased
1,153
Reduced
1,646
Closed
1,310

Sector Composition

Rank Sector Weight
1 Technology 2.73%
2 Financials 2.53%
3 Healthcare 2.3%
4 Consumer Discretionary 2.11%
5 Industrials 1.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIL
1401
DELISTED
Hill International, Inc. Common Stock
HIL
$46K ﹤0.01%
+14,514
New +$43.4K
SRLP
1402
DELISTED
SPRAGUE RESOURCES LP
SRLP
$46K ﹤0.01%
+2,719
New +$46.1K
BAH icon
1403
Booz Allen Hamilton
BAH
$9.15B
$45K ﹤0.01%
636
-1,324
-68% -$94.3K
BBH icon
1404
VanEck Biotech ETF
BBH
$422M
$45K ﹤0.01%
322
-3,654
-92% -$480K
CACC icon
1405
Credit Acceptance
CACC
$6.08B
$45K ﹤0.01%
101
-251
-71% -$111K
EW icon
1406
Edwards Lifesciences
EW
$51.7B
$45K ﹤0.01%
579
-12,849
-96% -$1M
GRMN
1407
Garmin
GRMN
$60B
$45K ﹤0.01%
461
-4,347
-90% -$405K
KALA icon
1408
KALA BIO
KALA
$14.5M
$45K ﹤0.01%
5
+3
+150% +$29K
LEA icon
1409
Lear
LEA
$8.18B
$45K ﹤0.01%
330
-1,738
-84% -$215K
LYTS icon
1410
LSI Industries
LYTS
$924M
$45K ﹤0.01%
7,460
+5,302
+246% +$29.2K
MRKR icon
1411
Marker Therapeutics
MRKR
$18.7M
$45K ﹤0.01%
1,574
+1,563
+14,209% +$56.9K
OTEX icon
1412
Open Text
OTEX
$6.04B
$45K ﹤0.01%
1,034
-29,290
-97% -$1.23M
PFLT icon
1413
PennantPark Floating Rate Capital
PFLT
$746M
$45K ﹤0.01%
3,657
+2,793
+323% +$33.2K
PLNT icon
1414
Planet Fitness
PLNT
$3.78B
$45K ﹤0.01%
600
-120
-17% -$8.09K
UBX
1415
DELISTED
Unity Biotechnology
UBX
$45K ﹤0.01%
627
-114
-15% -$8.04K
B
1416
DELISTED
Barnes Group Inc.
B
$45K ﹤0.01%
727
+323
+80% +$18.7K
FTSV
1417
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$45K ﹤0.01%
1,164
-2,968
-72% -$47.7K
GRA
1418
DELISTED
W.R. Grace & Co.
GRA
$45K ﹤0.01%
641
-551
-46% -$37K
CRI icon
1419
Carter's
CRI
$1.47B
$44K ﹤0.01%
400
-1,830
-82% -$185K
ETSY icon
1420
Etsy
ETSY
$7.85B
$44K ﹤0.01%
1,001
+154
+18% +$7.34K
HEDJ icon
1421
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.87B
$44K ﹤0.01%
+1,258
New +$43.4K
INTC icon
1422
Intel
INTC
$513B
$44K ﹤0.01%
732
-83,743
-99% -$4.69M
JBHT icon
1423
JB Hunt Transport Services
JBHT
$25.2B
$44K ﹤0.01%
379
-4,850
-93% -$557K
SHY icon
1424
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
$44K ﹤0.01%
515
+355
+222% +$30.1K
TBI
1425
Trueblue
TBI
$311M
$44K ﹤0.01%
1,848
+240
+15% +$5.47K

Similar funds

Tower Research Capital (TRC)'s Q4 2019 Portfolio in Review

As of Q4 2019, Tower Research Capital (TRC) held 4,943 positions worth $1.2B, down 17% from $1.46B the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Tower Research Capital (TRC) withdrew a net $342M in Q4 2019, closing 1,310 positions and reducing 1,646 holdings. Its most notable exit was Wells Fargo, an estimated $7.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 9.1% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2019 buy was iShares Core S&P 500 ETF: 75,634 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $168M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2019 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $52.3M.
  • Tower Research Capital (TRC) fully exited Wells Fargo in Q4 2019, selling an estimated $7.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 51% of its $1.2B portfolio in Q4 2019.
  • Tower Research Capital (TRC) opened 709 new positions and closed 1,310 in Q4 2019.
  • Tower Research Capital (TRC)'s portfolio value fell 17% quarter-over-quarter to $1.2B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.